Integra LifeSciences Holdings Cash on Hand 2012-2026 | IART

Integra LifeSciences Holdings cash on hand from 2012 to 2026. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Integra LifeSciences Holdings Annual Cash on Hand
(Millions of US $)
2025 $264
2024 $274
2023 $309
2022 $457
2021 $513
2020 $470
2019 $199
2018 $139
2017 $175
2016 $102
2015 $52
2014 $72
2013 $121
2012 $97
2011 $101
Integra LifeSciences Holdings Quarterly Cash on Hand
(Millions of US $)
2026-06-30 $274
2026-03-31 $266
2025-12-31 $264
2025-09-30 $268
2025-06-30 $254
2025-03-31 $273
2024-12-31 $274
2024-09-30 $278
2024-06-30 $297
2024-03-31 $663
2023-12-31 $309
2023-09-30 $274
2023-06-30 $309
2023-03-31 $307
2022-12-31 $457
2022-09-30 $512
2022-06-30 $447
2022-03-31 $407
2021-12-31 $513
2021-09-30 $470
2021-06-30 $397
2021-03-31 $409
2020-12-31 $470
2020-09-30 $396
2020-06-30 $361
2020-03-31 $358
2019-12-31 $199
2019-09-30 $208
2019-06-30 $176
2019-03-31 $157
2018-12-31 $139
2018-09-30 $206
2018-06-30 $184
2018-03-31 $189
2017-12-31 $175
2017-09-30 $482
2017-06-30 $155
2017-03-31 $135
2016-12-31 $102
2016-09-30 $108
2016-06-30 $87
2016-03-31 $77
2015-12-31 $52
2015-09-30 $79
2015-06-30 $131
2015-03-31 $80
2014-12-31 $72
2014-09-30 $140
2014-06-30 $137
2014-03-31 $129
2013-12-31 $121
2013-09-30 $119
2013-06-30 $99
2013-03-31 $90
2012-12-31 $97
2012-09-30 $126
2012-06-30 $115
2012-03-31 $112
2011-12-31 $101
2011-09-30 $111
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.184B $1.635B
Integra LifeSciences is one of the world leaders in regenerative medicine. The company develops, manufactures and markets cost-effective surgical implants and medical instruments. The company now manufactures and sells products in the following two global reportable business segments: Codman Specialty Surgical (CSS) and Orthopedics and Tissue Technologies (OTT). The CSS business offers global, market-leading technologies, brands and instrumentation. The global commercial network includes clinical specialists, a large direct global sales force and strategic partnerships and distributors that serve hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers and health care providers in North America, South America, Europe, Asia Pacific, Middle East and Africa. The Tissue Technologies segment includes wound reconstruction and repair products, bone grafts and nerve and tendon repair products.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $240.872B 27.34
Intuitive Surgical (ISRG) United States $138.955B 47.11
Edwards Lifesciences (EW) United States $50.820B 31.41
IQVIA Holdings (IQV) United States $43.853B 23.45
Waters (WAT) United States $41.424B 30.82
IDEXX Laboratories (IDXX) United States $40.308B 35.98
DexCom (DXCM) United States $33.717B 35.04
Alcon (ALC) Switzerland $32.170B 19.95
Mettler-Toledo (MTD) United States $27.898B 31.02
STERIS (STE) Ireland $19.991B 19.68
SONOVA HOLDING (SONVY) Switzerland $16.827B 0.00
Hologic (HOLX) United States $16.752B 17.53
Coloplast (CLPBY) Denmark $14.536B 17.43
Penumbra (PEN) United States $12.510B 82.49
Fresenius Medical Care AG KGaA (FMS) Germany $11.924B 8.35
Globus Medical (GMED) United States $9.946B 15.06
Glaukos (GKOS) United States $9.662B 0.00
Masimo (MASI) United States $9.578B 30.69
SARTORIUS (SSSGY) Germany $7.521B 43.67
Sysmex ADR (SSMXY) Japan $7.434B 28.12
Teleflex (TFX) United States $5.276B 14.23
LivaNova (LIVN) United Kingdom $4.298B 21.73
Integer Holdings (ITGR) United States $4.293B 19.89
Pulse Biosciences (PLSE) United States $3.814B 0.00
Veracyte (VCYT) United States $3.199B 26.18
TransMedics (TMDX) United States $2.987B 43.87
AxoGen (AXGN) United States $2.378B 0.00
UFP Technologies (UFPT) United States $2.143B 27.05
Elekta AB (EKTAY) Sweden $1.906B 17.83
Nihon Kohden (NHNKY) Japan $1.687B 15.45
Alphatec Holdings (ATEC) United States $1.572B 0.00
Alpha Tau Medical (DRTS) Israel $1.377B 0.00
OPKO Health (OPK) United States $1.246B 0.00
Tandem Diabetes Care (TNDM) United States $1.174B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.171B 27.77
Artivion (AORT) United States $1.138B 43.24
PROCEPT BioRobotics (PRCT) United States $1.105B 0.00
IRadimed (IRMD) United States $1.050B 45.88
Beta Bionics (BBNX) United States $0.985B 0.00
SiBone (SIBN) United States $0.802B 0.00
Anteris Technologies Global (AVR) Australia $0.795B 0.00
Mesa Laboratories (MLAB) United States $0.708B 17.05
AngioDynamics (ANGO) United States $0.638B 0.00
OrthoPediatrics (KIDS) United States $0.570B 0.00
Delcath Systems (DCTH) United States $0.559B 1611.00
Tactile Systems Technology (TCMD) United States $0.503B 20.56
NeuroPace (NPCE) United States $0.490B 0.00
Sight Sciences (SGHT) United States $0.442B 0.00
908 Devices (MASS) United States $0.435B 0.00
Pacific Biosciences Of California (PACB) United States $0.426B 0.00
ClearPoint Neuro (CLPT) United States $0.422B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.355B 0.00
Mobia Medical (MOBI) United States $0.351B 0.00
Semler Scientific (SMLR) United States $0.311B 2.32
Treace Medical Concepts (TMCI) United States $0.292B 0.00
Spectral Diagnostics (EDTXF) Canada $0.242B 0.00
Neuronetics (STIM) United States $0.221B 0.00
RxSight (RXST) United States $0.216B 0.00
Lucid Diagnostics (LUCD) United States $0.160B 0.00
FocalTherics (FOCL) France $0.156B 0.00
Inogen (INGN) United States $0.136B 0.00
EDAP TMS S.A (EDAP) France $0.124B 0.00
Microbot Medical (MBOT) United States $0.091B 0.00
LENSAR (LNSR) United States $0.087B 0.00
Hyperfine (HYPR) United States $0.083B 0.00
CVRx (CVRX) United States $0.081B 0.00
QT Imaging Holdings (QTIH) United States $0.078B 0.00
Zomedica (ZOMDF) United States $0.076B 0.00
Covalon Technologies (CVALF) Canada $0.073B 24.09
DarioHealth (DRIO) United States $0.071B 0.00
Nano-X Imaging (NNOX) Israel $0.058B 0.00
Positron (POSC) United States $0.058B 0.00
Rapid Micro Biosystems (RPID) United States $0.056B 0.00
Envoy Medical (COCH) United States $0.055B 0.00
Spectral AI (MDAI) United States $0.053B 0.00
Vaso (VASO) United States $0.052B 29.49
Sensus Healthcare (SRTS) United States $0.050B 0.00
Precision Optics (POCI) United States $0.049B 0.00
Baird Medical Investment Holdings (BDMD) $0.044B 0.00
QT Imaging Holdings (QTI) United States $0.036B 0.00
InspireMD (NSPR) United States $0.036B 0.00
Ekso Bionics Holdings (EKSO) United States $0.032B 0.00
PAVmed (PAVM) United States $0.032B 0.00
Accuray (ARAY) United States $0.028B 0.00
Adagio Medical Holdings (ADGM) United States $0.011B 0.00
ENDRA Life Sciences (NDRA) United States $0.008B 0.00
EnVVeno Medical (NVNO) United States $0.006B 0.00
Nanovibronix (NAOV) United States $0.004B 0.00
Bluejay Diagnostics (BJDX) United States $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Nuwellis (NUWE) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.003B 0.00
NexGel (NXGL) United States $0.003B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
WORK Medical Technology Group (WOK) China $0.000B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.000B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00